{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:49:56Z","timestamp":1788925796947,"version":"build-2803163510"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Human papillomavirus (HPV) is one of the most common sexually transmitted infections and is the cause of several different diseases in men and women. Although little is known about HPV infection in men, they are also in the risk group of HPV infection and play an important role in transmitting the virus to women.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To define the efficacy of the HPV vaccine through cross-immunization and its role in clearance of HPV infection, and to assess infection-associated factors in men.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This prospective randomized clinical study enrolled 171 evaluable men with genital warts between June 2009 and October 2013. After the initial treatment intervention, 91 patients were randomly assigned to receive HPV vaccine in three doses. Eighty patients were in the control (unvaccinated) group. One hundred-eleven men were single and 60 men were married. Patients who had previous treatment for pre-existing warts and medical disorders that needed chronic treatment or immunosuppression were not included in the randomization. Also 29 men with follow-up less than 12 months and incomplete vaccination were not included.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>The patients were assessed regarding age, condom use, marital status, number of visible genital warts, and smoking status. Post-treatment follow-up was monthly up to 12th month.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Mean age was 34\u00b17.6. One hundred fifteen patients were smokers. For the recurrence of warts, age, smoking, vaccination status were insignificant and marital status was significant in the univariable analysis; only marital status preserved significance (HR: 2.0 CI:1.29\u20133.12 P =0.002) in the multivariable analysis including vaccination status, marital status, and smoking.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Among the investigated factors vaccination status was not but marital status significantly influenced wart recurrence. Married men had more recurrences in our population. Larger multicenter randomized clinical trials are lacking and seriously required to investigate the therapeutic effect of current quadrivalent HPV vaccine in genital warts.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/jsm.12670","type":"journal-article","created":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T13:43:01Z","timestamp":1408023781000},"page":"2785-2791","source":"Crossref","is-referenced-by-count":38,"title":["Impact of the Quadrivalent HPV Vaccine on Disease Recurrence in Men Exposed to HPV Infection: A Randomized Study"],"prefix":"10.1093","volume":"11","author":[{"given":"Enis Rauf","family":"Coskuner","sequence":"first","affiliation":[{"name":"Department of Urology \u00a0 , Istanbul , Turkey"},{"name":"Acibadem University School of Medicine \u00a0 , Istanbul , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayyar Alp","family":"Ozkan","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Izmit , Turkey"},{"name":"Kocaeli University School of Medicine \u00a0 , Izmit , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayhan","family":"Karakose","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Istanbul , Turkey"},{"name":"Yeni Yuzyil University School of Medicine \u00a0 , Istanbul , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozdal","family":"Dillioglugil","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Izmit , Turkey"},{"name":"Kocaeli University School of Medicine \u00a0 , Izmit , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Cevik","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Istanbul , Turkey"},{"name":"Yeni Yuzyil University School of Medicine \u00a0 , Istanbul , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,11,1]]},"reference":[{"key":"2024032602360594700_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1363\/3600604","article-title":"Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000","volume":"36","author":"Weinstock","year":"2004","journal-title":"Perspect Sex Reprod Health"},{"key":"2024032602360594700_bib2","first-page":"33","article-title":"Human papillomaviruses","volume":"90","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"2007","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"2024032602360594700_bib3","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.olq.0000145851.76025.ad","article-title":"Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States","volume":"31","author":"Koshiol","year":"2004","journal-title":"Sex Transm Dis"},{"key":"2024032602360594700_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","article-title":"Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments","volume":"401","author":"Bernard","year":"2010","journal-title":"Virology"},{"key":"2024032602360594700_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479","article-title":"Chapter 1: Human papillomavirus and cervical cancer\u2013burden and assessment of causality","volume":"31","author":"Bosch","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"2024032602360594700_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jnci\/djs491","article-title":"Annual Report to the Nation on the Status of Cancer, 1975\u20132009, featuring the burden and trends in human papillomavirus (HPV)- associated cancers and HPV vaccination coverage levels","volume":"105","author":"Jemal","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"2024032602360594700_bib7","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1111\/j.1743-6109.2012.02828.x","article-title":"HPV vaccination for boys? Talking economic sense","volume":"9","author":"Garattini","year":"2012","journal-title":"J Sex Med"},{"issue":"suppl 3","key":"2024032602360594700_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vaccine.2006.05.115","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24","author":"Munoz","year":"2006","journal-title":"Vaccine"},{"key":"2024032602360594700_bib9","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"2024032602360594700_bib10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"N Engl J Med"},{"key":"2024032602360594700_bib11","first-page":"1","author":"Roberts JN US FDA, Clinical review of biologics license application supplement STN# 125126\/1297.0: Male indication for GARDASIL","year":"2008"},{"key":"2024032602360594700_bib12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.pop.2011.07.003","article-title":"Adult vaccination","volume":"38","author":"Hillson","year":"2011","journal-title":"Prim Care"},{"key":"2024032602360594700_bib13","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.vaccine.2006.11.049","article-title":"A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11","volume":"25","author":"Slupetzky","year":"2007","journal-title":"Vaccine"},{"key":"2024032602360594700_bib14","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1111\/jsm.12211","article-title":"Understanding human papillomavirus vaciination intentions: Comperative utility of the theory of reasoned action and the theory of planned behavior in vaccine target age women and men","volume":"10","author":"Fisher","year":"2013","journal-title":"J Sex Med"},{"key":"2024032602360594700_bib15","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1158\/1055-9965.EPI-08-0151","article-title":"The human papillomavirus infection in men study: Human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States","volume":"17","author":"Giuliano","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2024032602360594700_bib16","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1086\/342109","article-title":"External genital warts: Diagnosis, treatment, and prevention","volume":"35","author":"Wiley","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2024032602360594700_bib17","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high- grade cervical lesions","volume":"356","author":"Group","year":"2007","journal-title":"N Engl J Med"},{"key":"2024032602360594700_bib18","doi-asserted-by":"crossref","first-page":"e1401","DOI":"10.1136\/bmj.e1401","article-title":"Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: Retrospective pooled analysis of trial data","volume":"344","author":"Joura","year":"2012","journal-title":"Br Med J"},{"key":"2024032602360594700_bib19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/archdermatol.2010.71","article-title":"Recalcitrant cutaneous warts treated with recombinant quadrivalent human papillomavirus vaccine (types 6, 11, 16, and 18) in a developmentally delayed, 31-year-old white man","volume":"146","author":"Venugopal","year":"2010","journal-title":"Arch Dermatol"},{"key":"2024032602360594700_bib20","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1016\/j.jaad.2010.12.032","article-title":"Condyloma accuminatum treated with recombinant quadrivalent human papillomavirus vaccine (types 6, 11, 16, 18)","volume":"64","author":"Lee","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"2024032602360594700_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaad.2011.11.970","article-title":"Lack of efficacy in treating condyloma acuminata and preventing recurrences with the recombinant quadrivalent human papillomavirus vaccine in a case series of immunocompetent patients","volume":"68","author":"Kreuter","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"2024032602360594700_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1128\/CVI.05208-11","article-title":"Immunogenicity of the quadrivalent human papillomavirus (type 6\/11\/16\/18) vaccine in males 16 to 26 years old","volume":"19","author":"Hillman","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"2024032602360594700_bib23","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3201\/eid1406.0706162","article-title":"Transmission of human papillomavirus in heterosexual couples","volume":"14","author":"Hernandez","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"2024032602360594700_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/EDE.0b013e3181c1e70b","article-title":"Human papillomavirus infections among couples in new sexual relationships","volume":"21","author":"Burchell","year":"2010","journal-title":"Epidemiology"},{"key":"2024032602360594700_bib25","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1086\/431978","article-title":"Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads","volume":"41","author":"Bleeker","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2024032602360594700_bib26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/infdis\/jis327","article-title":"Genital human papillomavirus (HPV) concordance in heterosexual couples","volume":"206","author":"Nyitray","year":"2012","journal-title":"J Infect Dis"},{"key":"2024032602360594700_bib27","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/infdis\/174.4.679","article-title":"Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women","volume":"174","author":"Burk","year":"1996","journal-title":"J Infect Dis"},{"key":"2024032602360594700_bib28","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/infdis\/jir341","article-title":"Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003\u20132006","volume":"204","author":"Hariri","year":"2011","journal-title":"J Infect Dis"},{"key":"2024032602360594700_bib29","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jadohealth.2008.07.009","article-title":"Age-specific prevalence of infection with human papillomavirus in females: A global review","volume":"43","author":"Smith","year":"2008","journal-title":"J Adolesc Health"},{"key":"2024032602360594700_bib30","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10654-007-9180-8","article-title":"Smoking is an independent risk factor for oncogenic human papillomavirus (HPV) infections but not for high-grade CIN","volume":"22","author":"Syrjanen","year":"2007","journal-title":"Eur J Epidemiol"},{"key":"2024032602360594700_bib31","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/ije\/dyn033","article-title":"Smoking and human papillomavirus infection: Pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys","volume":"37","author":"Vaccarella","year":"2008","journal-title":"Int J Epidemiol"},{"key":"2024032602360594700_bib32","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1158\/1055-9965.EPI-09-0763","article-title":"Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load","volume":"18","author":"Xi","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515305932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515305932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/11\/11\/2785\/48359274\/jsm_11_11_2785.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/11\/11\/2785\/48359274\/jsm_11_11_2785.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T03:07:07Z","timestamp":1711422427000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/11\/11\/2785\/6958212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,1]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11,1]]},"published-print":{"date-parts":[[2014,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jsm.12670","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,11]]},"published":{"date-parts":[[2014,11,1]]}}}